71. Blood pressure-lowering medication and erectile dysfunction. (June 2015) Authors: Pucci, Mark; Patel, Rikesh Journal: Adverse drug reaction bulletin Issue: Volume 292:Number 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
72. Blood pressure-lowering medication and erectile dysfunction: are the drugs to blame?. (June 2015) Authors: Pucci, Mark; Patel, Rikesh Journal: Adverse drug reaction bulletin Issue: Volume 292:Number 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
73. Calcium supplements and cardiovascular risk: 5 years on. (October 2013) Authors: Bolland, Mark J.; Grey, Andrew; Reid, Ian R. Journal: Therapeutic advances in drug safety Issue: Volume 4:Number 5(2013) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
74. Can supporting health literacy reduce medication-related harm in older adults?. (March 2018) Authors: Parekh, Nikesh; Ali, Khalid; Davies, Kevin; Rajkumar, Chakravarthi Journal: Therapeutic advances in drug safety Issue: Volume 9:Number 3(2018) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
75. Cardiotoxicity in relation to treatment with aromatase inhibitors in breast cancer. (February 2022) Authors: Lund, Marie; Ejlertsen, Bent Journal: Adverse drug reaction bulletin Issue: Volume 332:Number 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
76. Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. (June 2017) Authors: Fanelli, Andrea; Ghisi, Daniela; Aprile, Pierangelo Lora; Lapi, Francesco Journal: Therapeutic advances in drug safety Issue: Volume 8:Number 6(2017) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
77. Cardiovascular risk with DPP-4 inhibitors: latest evidence and clinical implications. (April 2016) Authors: Karagiannis, Thomas; Bekiari, Eleni; Boura, Panagiota; Tsapas, Apostolos Journal: Therapeutic advances in drug safety Issue: Volume 7:Number 2(2016:Apr.) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
78. Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors. (August 2014) Authors: Onitilo, Adedayo A.; Engel, Jessica M.; Stankowski, Rachel V. Journal: Therapeutic advances in drug safety Issue: Volume 5:Number 4(2014:Aug.) Page Start: 154 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
79. Case series of docetaxel-induced dorsal hand–foot syndrome. (August 2018) Authors: Patel, Jolly; Ringley, J. Tanner; Moore, Donald C. Journal: Therapeutic advances in drug safety Issue: Volume 9:Number 8(2018) Page Start: 495 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
80. Ceftolozane–tazobactam for the treatment of osteomyelitis caused by multidrug-resistant pathogens: a case series. (July 2019) Authors: Tan, Xing; Moenster, Ryan P. Journal: Therapeutic advances in drug safety Issue: Volume 10(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗